BGLU9 Antibody

What is BGLU9 and why is it a significant research target in Arabidopsis thaliana?

BGLU9 (Beta-Glucosidase 9) is a protein encoded by the BGLU9 gene in Arabidopsis thaliana with UniProt accession number Q9STP4. This enzyme belongs to the beta-glucosidase family, which plays crucial roles in plant defense mechanisms, hormone regulation, and secondary metabolite activation. The significance of BGLU9 stems from its involvement in glucosinolate metabolism pathways, which are important for plant defense against herbivores and pathogens. Researchers target BGLU9 to understand fundamental plant biochemical processes and stress responses, particularly in the Brassicaceae family .

What detection methods are validated for BGLU9 Antibody in Arabidopsis research?

The BGLU9 Antibody has been validated for multiple detection methods in Arabidopsis research:

• Western Blot (WB): The primary application, typically requiring 1-2 μg/ml concentration for optimal detection of native and recombinant BGLU9 protein

• ELISA: Validated for quantitative detection, with typical working dilutions between 1:1000 to 1:5000

• Immunohistochemistry: Though less common, can be used for tissue localization studies

For optimal results in Western blot applications, researchers should use reducing conditions with either PVDF or nitrocellulose membranes, and blocking with 5% non-fat dry milk in TBST is recommended. The antibody detects both natural and recombinant BGLU9 protein, with strongest reactivity against Arabidopsis thaliana samples .

How should BGLU9 Antibody be stored and handled to maintain optimal activity?

BGLU9 Antibody requires careful storage and handling to maintain its detection capacity:

• Storage temperature: Upon receipt, store at -20°C or -80°C

• Avoid repeated freeze-thaw cycles: Aliquot the antibody into smaller volumes before freezing

• Buffer conditions: Typically supplied in a stabilizing buffer containing 50% Glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as preservative

• Working dilutions: Prepare working dilutions fresh on the day of experiment

• Shelf life: When properly stored, the antibody maintains activity for approximately 12 months

• Shipping condition: Shipped with ice packs; check for any signs of degradation upon arrival

Following these guidelines will help maintain antibody specificity and sensitivity, ensuring reliable experimental results .

How can I optimize protein extraction protocols for BGLU9 detection in plant tissues?

Optimizing protein extraction is critical for successful BGLU9 detection:

• Tissue selection and harvesting:

  • Collect young leaf tissue (preferably 2-3 weeks old) as BGLU9 expression may vary with developmental stage

  • Flash freeze in liquid nitrogen immediately after collection

  • Store at -80°C until extraction if not processed immediately

• Extraction buffer composition:

  • Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100

  • Add fresh protease inhibitors (e.g., 1 mM PMSF, 1 μg/ml leupeptin, 1 μg/ml aprotinin)

  • Include 5 mM DTT to maintain reducing conditions for optimal antibody binding

• Extraction procedure:

  • Grind tissue thoroughly in liquid nitrogen using a mortar and pestle

  • Add extraction buffer (1:3 tissue:buffer ratio)

  • Incubate with gentle rotation for 30 minutes at 4°C

  • Centrifuge at 13,000 × g for 15 minutes at 4°C

  • Collect supernatant for analysis

• Protein quantification:

  • Use Bradford or BCA assay for accurate protein quantification

  • Typically load 20-50 μg total protein per lane for Western blot analysis

This optimized protocol ensures maximum extraction of BGLU9 while minimizing degradation, improving detection sensitivity with the BGLU9 Antibody .

What are the recommended controls when using BGLU9 Antibody in experimental workflows?

Implementing appropriate controls is essential for accurate interpretation of BGLU9 Antibody results:

Positive Controls:

• Recombinant Arabidopsis thaliana BGLU9 protein (when available)

• Arabidopsis thaliana wild-type leaf extract (Columbia-0 ecotype recommended)

• Positive control tissue with known high BGLU9 expression

Negative Controls:

• Primary antibody omission control

• Arabidopsis BGLU9 knockout/knockdown mutant tissue (if available)

• Non-plant protein extracts (e.g., E. coli lysate without plant protein expression)

• Secondary antibody-only control

Specificity Controls:

• Pre-adsorption control using the immunizing peptide

• Cross-reactivity assessment with related BGLU family members

• Testing antibody performance in multiple plant species if cross-species reactivity is claimed

Loading Controls:

• Constitutively expressed plant proteins (e.g., actin, tubulin, or GAPDH)

• Total protein staining methods (e.g., Ponceau S, SYPRO Ruby)

Implementing these controls ensures experimental validity and helps troubleshoot any issues with antibody specificity or sensitivity .

How should expression levels of BGLU9 be quantified in comparative studies across different plant tissues?

Accurate quantification of BGLU9 expression across tissues requires a systematic approach:

• Protein-level quantification methods:

  • Western blot densitometry:

    • Use calibration curves with purified recombinant BGLU9 protein

    • Normalize to loading controls (actin/tubulin)

    • Analyze with image analysis software (ImageJ, Image Lab)

    • Use at least three biological replicates

  • ELISA-based quantification:

    • Develop standard curves using purified BGLU9 protein

    • Perform in triplicate with appropriate controls

    • Calculate concentration based on standard curve

• RNA-level quantification:

  • RT-qPCR:

    • Design primers specific to BGLU9 (avoid cross-amplification with other BGLU family members)

    • Use validated reference genes (e.g., ACT2, UBQ10, EF1α)

    • Apply the 2^-ΔΔCt method for relative quantification

    • Include no-template and no-RT controls

• Data normalization strategies:

  • Normalize to total protein concentration

  • Use multiple reference genes/proteins for more accurate normalization

  • Account for developmental stage and growth conditions

  • Consider tissue-specific reference genes when comparing diverse tissues

• Statistical analysis:

  • Apply appropriate statistical tests (ANOVA, t-test) based on experimental design

  • Include at least three biological replicates and technical triplicates

  • Report both statistical significance and effect size

This comprehensive approach enables reliable comparison of BGLU9 expression across different tissues, developmental stages, or experimental conditions .

What are the most common issues with BGLU9 detection in Western blots and how can they be resolved?

Researchers frequently encounter several challenges when detecting BGLU9 in Western blots:

For persistent issues, consider these advanced techniques:

• Use purified recombinant BGLU9 as positive control

• Test alternative membrane types (PVDF vs. nitrocellulose)

• Try different blocking reagents (milk vs. BSA)

• Consider alternative detection systems (fluorescence-based vs. chemiluminescence) .

How can specificity of BGLU9 Antibody be validated against related beta-glucosidases in Arabidopsis?

Validating BGLU9 Antibody specificity requires systematic testing against related beta-glucosidases:

• Sequence analysis approach:

  • Perform sequence alignment of BGLU family members in Arabidopsis

  • Identify sequence similarity percentages between BGLU9 and related proteins

  • Predict potential cross-reactivity based on immunogen sequence

• Experimental validation methods:

  • Recombinant protein panel testing:

    • Express and purify multiple BGLU family members

    • Perform Western blot analysis under identical conditions

    • Compare binding affinity and signal intensity

  • Genetic knockout/knockdown validation:

    • Test antibody against BGLU9 knockout mutants (complete absence of signal expected)

    • Test in BGLU9 RNAi or CRISPR knockdown lines (reduced signal expected)

    • Use overexpression lines as positive controls

  • Peptide competition assay:

    • Pre-incubate antibody with excess immunizing peptide

    • Perform parallel Western blots with and without peptide pre-absorption

    • Specific signals should be blocked by the peptide

• Cross-reactivity assessment table:

These validation approaches ensure confidence in antibody specificity, critical for accurate interpretation of experimental results involving closely related BGLU family members .

What factors influence batch-to-batch variability in BGLU9 Antibody performance?

Batch-to-batch variability in polyclonal antibodies like BGLU9 Antibody can significantly impact experimental reproducibility. Understanding these factors helps researchers mitigate inconsistencies:

• Source-related factors:

  • Variations in immunogen quality and purity

  • Individual rabbit immune response differences

  • Serum collection timing and processing methods

  • Purification efficiency of antigen-affinity methods

• Manufacturing variables:

  • Differences in antibody purification procedures

  • Variations in storage buffer composition

  • Inconsistent quality control thresholds

  • Changes in validation protocols between batches

• Minimizing impact on experiments:

  • Reserve large quantities of a single batch for long-term projects

  • Validate each new batch against previous batches using standard samples

  • Document lot numbers and create internal calibration standards

  • Determine optimal working concentrations for each batch

  • Consider using recombinant monoclonal antibodies when available for critical applications

• Quantitative assessment of batch variability:

  • Perform titration experiments to determine EC50 values

  • Compare signal-to-noise ratios across batches

  • Analyze epitope recognition patterns through peptide arrays

  • Evaluate differences in non-specific binding profiles

When significant batch variations are observed, researchers should normalize data or adjust protocols accordingly to maintain experimental consistency across different antibody lots .

How can BGLU9 Antibody be utilized for immunolocalization studies in plant tissues?

Immunolocalization with BGLU9 Antibody requires specialized protocols for plant tissues:

• Sample preparation options:

  • Paraffin embedding: Provides good morphological preservation

    • Fix tissues in 4% paraformaldehyde, 0.1% glutaraldehyde in PBS

    • Dehydrate through ethanol series (30-100%)

    • Embed in paraffin and section at 5-10 μm thickness

  • Cryosectioning: Better antigen preservation

    • Fix tissues briefly (1 hour) in 4% paraformaldehyde

    • Cryoprotect in 30% sucrose solution

    • Embed in OCT medium and section at 10-15 μm thickness

  • Whole-mount technique: For seedlings and thin tissues

    • Fix in 4% paraformaldehyde for 30 minutes

    • Permeabilize with 0.1-0.5% Triton X-100

    • Proceed directly to immunostaining

• Optimized immunostaining protocol:

  • Block with 3% BSA, 5% normal serum in PBS for 1-2 hours

  • Incubate with BGLU9 Antibody (5-10 μg/ml) overnight at 4°C

  • Wash extensively (5× 10 minutes) with PBS + 0.1% Tween-20

  • Apply fluorescent secondary antibody (1:200-1:500) for 2 hours

  • Counterstain cell walls with Calcofluor White

  • Mount in anti-fade medium containing DAPI

• Advanced microscopy approaches:

  • Confocal microscopy for high-resolution subcellular localization

  • Super-resolution microscopy for nanoscale distribution

  • Co-localization studies with organelle markers

  • Live-cell imaging with minimally fixed tissues

• Validation controls specific for plant immunohistochemistry:

  • Tissue from BGLU9 knockout plants

  • Primary antibody omission

  • Peptide competition controls

  • Autofluorescence controls (critical for plant tissues)

This comprehensive approach enables precise cellular and subcellular localization of BGLU9 protein in diverse plant tissues, revealing important information about its functional compartmentalization .

What strategies can be employed to develop recombinant monoclonal antibodies against BGLU9 for improved reproducibility?

Developing recombinant monoclonal antibodies against BGLU9 offers significant advantages over traditional polyclonal antibodies. The following strategies can be employed:

• Antibody discovery platforms:

  • Phage display technology:

    • Create diverse antibody fragment (scFv or Fab) libraries

    • Select high-affinity binders through multiple rounds of panning

    • Screen against specific BGLU9 epitopes or full-length protein

  • Single B cell isolation:

    • Immunize animals with BGLU9 protein or peptides

    • Isolate antigen-specific B cells using FACS

    • Sequence VH and VL genes from single cells

  • Humanized antibody development:

    • Graft CDRs from mouse antibodies onto human frameworks

    • Engineer for improved affinity and reduced immunogenicity

• Production and expression systems:

  • Mammalian cell expression:

    • Co-transfect HEK293 cells with heavy and light chain vectors (2:3 ratio)

    • Culture in suspension for 5-7 days

    • Purify using Protein A/G affinity chromatography

  • Plant-based expression systems:

    • Express in Nicotiana benthamiana through Agrobacterium infiltration

    • Extract and purify using appropriate affinity tags

    • Offers advantages for plant protein antibodies (proper glycosylation)

• Antibody engineering approaches:

  • Affinity maturation:

    • Introduce targeted mutations in CDR regions

    • Select variants with improved binding kinetics

    • Optimize off-rate for stable binding

  • Format diversification:

    • Convert between different formats (IgG, Fab, scFv)

    • Engineer bispecific antibodies targeting BGLU9 and other proteins

    • Develop antibody-enzyme fusions for enhanced detection

• Quality control parameters:

  • Sequence verification of VH and VL regions

  • Binding kinetics determination (ka, kd, KD) via SPR

  • Thermal stability assessment (Tm, aggregation propensity)

  • Epitope binning to ensure diverse recognition sites

Implementing these strategies can lead to renewable, highly specific monoclonal antibodies against BGLU9 with defined epitope recognition and consistent performance across experiments .

How can BGLU9 Antibody be integrated into multi-omics approaches for studying plant stress responses?

Integrating BGLU9 Antibody into multi-omics research provides comprehensive insights into plant stress responses:

• Proteomics integration:

  • Immunoprecipitation-mass spectrometry (IP-MS):

    • Use BGLU9 Antibody to isolate protein complexes

    • Identify interaction partners via LC-MS/MS

    • Map protein-protein interaction networks during stress

  • Phosphoproteomics analysis:

    • Immunoprecipitate BGLU9 under stress conditions

    • Analyze phosphorylation changes via MS

    • Correlate with kinase activity and signaling cascades

  • Protein turnover studies:

    • Track BGLU9 degradation kinetics under stress

    • Combine with proteasome inhibitors to assess stability

    • Identify post-translational modifications regulating stability

• Transcriptomics correlation:

  • Compare BGLU9 protein levels with transcript abundance

  • Integrate with RNA-seq data from stress experiments

  • Identify discrepancies indicating post-transcriptional regulation

  • Analyze co-expression networks to predict functional relationships

• Metabolomics connections:

  • Correlate BGLU9 expression with changes in glucosinolate profiles

  • Map substrate-product relationships through metabolite analysis

  • Identify novel metabolic pathways influenced by BGLU9 activity

• Data integration framework:

  • Experimental design considerations:

    • Synchronized sampling across platforms

    • Consistent stress application protocols

    • Inclusion of multiple time points to capture dynamics

  • Computational integration approaches:

    • Use pathway enrichment analysis to connect datasets

    • Apply machine learning for pattern recognition

    • Develop network models incorporating protein, transcript, and metabolite data

• Visualization of multi-omics data:

This integrated approach provides a systems-level understanding of BGLU9's role in stress responses, revealing regulatory mechanisms and potential targets for crop improvement .

What are the methodological considerations for studying BGLU9 protein-protein interactions in planta?

Investigating BGLU9 protein-protein interactions in planta requires specialized approaches:

• In vivo interaction detection methods:

  • Bimolecular Fluorescence Complementation (BiFC):

    • Tag BGLU9 and candidate interactors with split fluorescent protein halves

    • Express in Arabidopsis protoplasts or stable transgenic lines

    • Visualize interaction through fluorescence microscopy

    • Control for protein expression levels and spontaneous fluorophore assembly

  • Förster Resonance Energy Transfer (FRET):

    • Tag BGLU9 with donor fluorophore (e.g., CFP)

    • Tag candidate interactors with acceptor fluorophore (e.g., YFP)

    • Measure energy transfer as evidence of physical proximity

    • Calculate FRET efficiency and perform acceptor photobleaching controls

  • Co-immunoprecipitation with BGLU9 Antibody:

    • Cross-link proteins in intact plant tissues (optional)

    • Extract under native conditions

    • Immunoprecipitate with BGLU9 Antibody

    • Identify interactors through mass spectrometry

    • Validate key interactions with reciprocal co-IPs

• Proximity-dependent labeling approaches:

  • BioID or TurboID fusion with BGLU9:

    • Generate fusion proteins with biotin ligase

    • Express in planta and provide biotin

    • Purify biotinylated proteins (proximity partners)

    • Identify through mass spectrometry

    • Distinguish between direct and indirect interactions

• Membrane-associated interaction considerations:

  • Use specialized extraction buffers with mild detergents

  • Consider split-ubiquitin yeast two-hybrid for membrane proteins

  • Implement Blue-Native PAGE for intact complex isolation

  • Validate localization with subcellular fractionation

• Quantitative interaction assessment:

  • Apply MYTH (Membrane Yeast Two-Hybrid) for quantification

  • Use protein complementation assays with luciferase

  • Perform Surface Plasmon Resonance for binding kinetics

  • Implement Microscale Thermophoresis for in-solution measurements

• Biological validation experiments:

  • Generate genetic knockouts of interaction partners

  • Analyze phenotypic consequences and BGLU9 function

  • Perform domain mapping to identify interaction interfaces

  • Correlate interactions with physiological responses

These methodologies provide comprehensive insights into BGLU9's protein interaction network, revealing functional complexes and regulatory mechanisms in native plant contexts .

What are the most authoritative reference sources for BGLU9 research and applications?

The following resources provide authoritative information for BGLU9 research:

• Protein Databases and Repositories:

  • UniProt (Q9STP4): Comprehensive protein information including sequence, domains, and functional annotation

  • TAIR (The Arabidopsis Information Resource): Gene models, expression data, and mutant resources

  • Protein Data Bank (PDB): Structural information for beta-glucosidases

  • BRENDA: Enzyme functional and kinetic data

• Antibody Validation Resources:

  • Antibodypedia: Independent validation data for commercial antibodies

  • CiteAb: Citation-based antibody search engine

  • The Antibody Registry: Unique identifiers for antibody reagents

• Key Literature:

  • Original characterization papers for BGLU9 function

  • Methodology papers for plant protein extraction and antibody validation

  • Comparative studies of beta-glucosidase family members in Arabidopsis

• Bioinformatics Tools:

  • BLAST for sequence comparisons among BGLU family members

  • PSORT for subcellular localization prediction

  • NetPhos for phosphorylation site prediction

  • ProtParam for physicochemical property analysis

• Commercial Resources:

  • Vendor-specific validation data and application notes

  • Technical support for troubleshooting experiment-specific issues

  • Custom services for epitope mapping and antibody characterization

Researchers should critically evaluate resources and prioritize peer-reviewed publications and well-established databases when gathering information for BGLU9 studies .